Please login to the form below

Not currently logged in
Email:
Password:

personalised treatments

This page shows the latest personalised treatments news and features for those working in and with pharma, biotech and healthcare.

Roche/GE’s digital medicine alliance bears first fruit

Roche/GE’s digital medicine alliance bears first fruit

Roche says that the launch of NAVIFY Tumour Board is an “important step in [its] personalised healthcare strategy to fit treatments to patients who can benefit most from a specific therapy.”.

Latest news

More from news
Approximately 1 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Cannes Lions Healthcare Agency of the Year – championing change and demanding more… Cannes Lions Healthcare Agency of the Year – championing change and demanding more…

    AI and machine learning are revolutionising how we understand and use that data, helping us to develop new, more personalised treatments more quickly and more cheaply than we ever thought possible. ... But the reality of the best and most advanced

  • Reactivating drug research programmes Reactivating drug research programmes

    The actual number of drug trials that are abandoned each year before treatments reach the marketplace is unknown, at least at a global level. ... However, as drugs like Herceptin have shown, as long as there is a high degree of efficacy in a small group

  • Winning the war against cancer Winning the war against cancer

    Dr Josep Figueras on survival, access to treatments and the need for good data in oncology. ... The next five years are expected to see a wave of new oncology medicines that will address significant unmet medical needs, with personalised treatments being

  • Another lost decade for research? Another lost decade for research?

    We are emerging from a decade of intensive research into rare disease treatments. ... Such technologies, which allow doctors to diagnose bacterial from viral infections or distinguish between different bacteria, could lead to personalised treatments and

  • What can pharma learn from Olympic sports coverage? What can pharma learn from Olympic sports coverage?

    marketing channels into the medical community, and it has got the research base to help translate emerging genomic discoveries into clinical information and personalised treatments in development. ... If personalised healthcare is going to expand

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Horizon adds AZ’s Galbraith to board Horizon adds AZ’s Galbraith to board

    Galbraith is senior VP and head of oncology innovative medicines at AZ and knows Horizon well thanks to a collaboration between the two companies on personalised cancer treatments.

  • Horizon appoints board chair Horizon appoints board chair

    These growth prospects include a partnership with AstraZeneca to research personalised treatments in oncology.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics